TransMed Systems
Cupertino
About TransMed Systems
TransMed Systems develops and deploys software solutions that facilitate exploration, reporting, and analysis of clinical, molecular, and healthcare operational data. TransMed's BIS provides an integrated bio-informatics platform enabling clinical and research organizations to aggregate data from multiple sources, easily explore data, and perform research and/or practice specific analysis. TransMed's platform unlocks the potential of the healthcare repository by tightly integrating analytics with aggregated data providing self-service analysis of all bio-clinical data sources in a framework usable by clinicians and investigators. Our solutions are used by health sciences researchers as well as clinicians interested in the application of information technology to the challenges of basic research and turning research into improved clinical practices. Our Bioinformatics solution is composed of four core capabilities leveraging our meta-data driven repository that aggregates data from disparate health data sources.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $8.4M
- Last round: Series Unknown (Aug 2014)
- Website: xbtransmed.com
- Phone: +1 605-886-5723
Industries & Categories
Clinical Trials, Information Technology, Software
Social Profiles
Canonical: https://fsome.com/organization/transmed-systems-269865 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.